Italian diagnostics group DiaSorin to buy Luminex for $1.8 bln
By Gomez in Business
Updated 3 years ago
April 11 (Reuters) - Italian diagnostics group DiaSorin SpA said on Sunday it will acquire U.S. based Luminex Corp for $1.8 billion in an all-cash deal that will strengthen DiaSorin’s molecular diagnostics technology. Luminex shareholders will receive $37 for each of Luminex share, DiaSorin said in a statement. The transaction,...
